Searched for
FUJIFILM PHARMA
Nikkei snaps 4-day losing streak, but Delta worries persistThe Nikkei rose 0.59% to 27,585.91, reversing its earlier losses when it hit its lowest level since July 30. The broader Topix rose 0.44% t...- Indian envoy holds meetings with CEOs of top US companies on COVID-19 crisisDuring the virtual meeting, Sandhu also highlighted that the knowledge and education partnership is a key pillar of the India US relationsh...
- Sun Pharma latest to sell COVID-19 drug favipiravir in India, to cost Rs 35 per tabletFavipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...
- Indian drug companies start off a price war on experimental Covid-19 drugOver the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...
- Trending stocks: Dr. Reddy's Laboratories shares up nearly 1%A total of 9,119 shares changed hands on the counter till 11:07AM (IST).
- Dr Reddy’s partners Fujifilm to launch Avigan for Covid-19 treatmentThe agreement provides for Fujifilm Toyama Chemical, a unit of the Japanese company to grant Dr. Reddy's and Dubai-based Global Response Ai...
- Local Covid drug makers ramp up capacityThis follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have ...
- Glenmark Pharma to study potential Covid-19 drug combinationThe study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...
- Strides Pharma to conduct trials in India for potential COVID-19 drugThe Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country...
- Trending stocks: Hikal shares jump 5% on development of Favipiravir APIA total of 32,209 shares changed hands on the counter till 11:40AM (IST).
- Glenmark pharma starts clinical trial on antiviral Favipiravir for Covid-19 treatmentThe drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...
- Biocon's partner firm launches diabetes product in JapanIn March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.
- Sun Pharma’s Novartis deal could be a bright spotSun Pharma’s acquisition of 14 established prescription brands of Swiss drug maker Novartis in Japan will give it a headstart in the $73 bi...
- Approval for insulin biosimilar in Japan a milestone for Biocon: Kiran Mazumdar Shaw, BioconThis will also help Biocon enter the US and European markets in the near future
- Natco takes a beating on FDA observation“The company believes there would be no adverse impact to its current or future pipeline products coming from these facilities,” Natco Phar...
- Biocon gets nod to sell its diabetes product 'Insulin Glargine' in JapanBiocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country.
- Fujifilm, Dr Reddy’s call off Japanese JV pactDr. Reddy's Laboratories and Japan's Fujifilm Corp have decided to terminate joint venture partnership they entered into in July 2011.
- Dr Reddy’s calls off joint venture with Fujifilm; stock upThe two companies had conducted detailed studies on the establishment of a joint venture for developing and manufacturing generic drugs.
- Piramal Healthcare signs pact with Japan's Fujifilm DiosynthMumbai-based Piramal Healthcare has teamed up with Japan's Fujifilm Diosynth for a contract manufacturing deal that would look to develop a...
- Dr Reddy's Laboratories may seal pact with Fujifilm for Japanese JV by JuneDr Reddy's Laboratories expects to sign a definitive agreement by June with Japan-based Fujifilm for a joint venture that will develop and ...
Load More
